ReportGem ReportGem 中文

GLOBAL RESEARCH ARCHIVE

Becle, S.A.B. de C.V. U.S. Reset Extends - Destocking + Distribution Re-Org Keep Share and Margin Risks High

Published: 2026-05-12Institution: JPMorganCompany / ticker: CUERVO.MXPages: 28Original language: 英语Evidence page: 2

Research evidence excerpt

Becle, S.A.B. de C.V. U.S. Reset Extends - Destocking + Distribution Re-Org Keep Share and Margin Risks High

Froylan Mendez AC Latin America Equity Research

(52-55) 5540-9482 11 May 2026 J P M O R G A N

froylan.mendez@jpmchase.com

Price Performance Summary Investment Thesis and Valuation

Investment Thesis

Becle has a broad spirits portfolio that spans a number of

categories and is the absolute market leader in the tequila

category both in the United States and globally. However, the

spirits industry is facing a longer than expected demand

normalization period, especially in the US, and a heightened

competitive environment, including in Cuervo’s core

categories. In this scenario, margin tailwinds for Cuervo coming

from lower input costs and a weaker MXN could be largely

offset as the industry competes to maintain share through

YTD 1m 3m 12m pricing. Furthermore, visibility on the length and depth of

Abs -34.1% -17.3% -28.1% -46.4% diminished pricing power is very low at this point, leading us to

Rel -43.3% -17.6% -26.2% -70.1%

adopt a more conservative view on LT gross margins for the

Company Data company, which we now expect to stabilize below pre-pandemic

Shares O/S (mn) 3,591 levels.

52-week range (Ps) 25.68-13.55

Market cap ($ mn) 2,851.68 Valuation

Exchange rate 17.18 We rate Becle/Cuervo shares Neutral. We have a Dec 2026 target

Free float (%) 13.3%

3M ADV (mn) 3.68 price of Ps16/share. Our price target is based on a 10yr DCF,

3M ADV ($ mn) 3.4 which embeds a 12.0% Ke and a 4.0% LT growth rate.

Volatility (90 Day) 34

Index MEXBOL

BBG ANR (Buy | Hold | Sell) 5|6|2 Performance Drivers

Key Metrics (FYE Dec)

Ps in millions FY25A FY26E FY27E

Financial Estimates

Revenue 43,089 38,397 40,531

Adj. EBITDA 10,303 7,439 8,251

Adj. EBIT 8,954 6,052 6,842

Adj.

The English excerpt is extracted automatically from the cited source page and may contain layout or recognition errors. It is never batch translated.

Open report viewer